Abstract Purpose of the Review Esophageal cancer is the sixth most common cause of
cancer death globally. Squamous cell carcinoma of the esophagus (ESCC) is the …

Esophageal squamous cell carcinoma (ESCC) is one of the most common malignancies
worldwide, especially in East Asia. ESCC accounts for more than 90% of esophageal …

Oesophageal cancer is the 19th most common cancer in the European Union (EU), with∼
45 900 new cases diagnosed in 2012 (1% of the total). In the EU, the highest age …

Background Neoadjuvant therapy improves long-term survival after oesophagectomy,
treating oesophageal cancer, but the evidence to date is insufficient to determine which of …

The crude incidence of oesophageal cancer in the European Union (EU) is about 4.5
cases/100 000/year (43 700 cases) with considerable geographical differences within the …

Objective: To investigate the relationship between postoperative complications and long-
term survival in patients with surgically resected esophageal squamous cell carcinoma …

The combination of docetaxel, cisplatin, and 5‐fluorouracil (DCF) as preoperative treatment
for esophageal squamous cell carcinoma (ESCC) has not been investigated. We carried out …

Esophageal cancer is characterized by early and frequent metastasis. Surgery is the primary
treatment for early-stage disease, whereas patients with patients with locally advanced …

Esophageal squamous cell carcinoma (ESCC), the most common subtype of esophageal
cancer in East Asian countries, is a devastating disease characterized by distinctly high …

Background The aim of this study was to report on the 5-year survival outcomes of patients
with resectable esophageal carcinoma who were treated by definitive chemoradiotherapy …